Literature DB >> 11201872

Peripheral neuropathy in leprosy and its consequences.

W H Van Brakel1.   

Abstract

Leprosy causes a 'mononeuritis multiplex' of immunological origin that results in autonomic, sensory and motor neuropathy. When detected and treated early, primary impairments may be reversible. However, 11-51% of patients do not recover. In addition, 33-56% of newly registered patients already have clinically detectable impairments, often no longer amenable to drug treatment. Among new patients, 6-27% present with secondary impairments, such as wounds, contractures and shortening of digits. All patients with impairments should be taught methods to prevent further impairment and subsequent disability (POID). As the result of impairments, many people experience limitation of activities of daily living, which can be partially overcome with the help of assistive devices, training, and surgery. As a result of these limitations, because of visible impairments, or simply because of the diagnosis 'leprosy', many people are restricted in their participation in society. Many overcome activity limitations and participation restrictions without assistance, despite residual impairments. However, some require intervention, such as physical or occupational therapy, reconstructive surgery or temporary socioeconomic assistance. Information on these issues is not collected routinely, and the few tools that exist to measure the severity or extent of impairment have not been widely used, nor have they been used to generate cohort-based statistics. There are no agreed indicators for monitoring POID activities or rehabilitation interventions. Work in the general field of rehabilitation has resulted in the ICIDH-2, which provides a conceptual framework for rehabilitation and the entire area of 'consequences of health conditions'. Although experience to date is very limited, the conceptual framework appears appropriate to leprosy. Data on the prevalence and incidence of primary and secondary impairments have been reported from several countries, the link between impairments and activity limitations has been investigated, and a few studies of the magnitude of the need for rehabilitation have been reported. Research priorities include studies of methods to improve detection of autonomic, sensory and motor neuropathy; trials of alternative drugs or regimens for treating neuropathy; studies of the use of various POID-monitoring systems that may be derived from these; studies of the design and use of instruments to assess limitations of activities and restrictions on participation; assessments of needs for rehabilitation and the development of methods to do these; studies of the efficacy of various types of rehabilitation interventions for particular conditions; and studies of the cost-effectiveness of such interventions.

Entities:  

Mesh:

Year:  2000        PMID: 11201872     DOI: 10.5935/0305-7518.20000086

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  7 in total

Review 1.  Leprosy.

Authors:  W Cairns S Smith; Paul Saunderson
Journal:  BMJ Clin Evid       Date:  2010-06-28

Review 2.  Leprosy.

Authors:  Diana Nj Lockwood
Journal:  BMJ Clin Evid       Date:  2007-04-01

3.  Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD 1).

Authors:  W Cairns S Smith; Alison M Anderson; Stephen G Withington; Wim H van Brakel; Richard P Croft; Peter G Nicholls; Jan Hendrik Richardus
Journal:  BMJ       Date:  2004-05-24

4.  A clinical decision support system with an integrated EMR for diagnosis of peripheral neuropathy.

Authors:  Reeda Kunhimangalam; Sujith Ovallath; Paul K Joseph
Journal:  J Med Syst       Date:  2014-04-02       Impact factor: 4.460

5.  Peripheral Neuropathy Due to Leprosy.

Authors:  Sharon P. Nations; Richard J. Barohn
Journal:  Curr Treat Options Neurol       Date:  2002-05       Impact factor: 3.972

6.  Two randomized controlled clinical trials to study the effectiveness of prednisolone treatment in preventing and restoring clinical nerve function loss in leprosy: the TENLEP study protocols.

Authors:  Inge Wagenaar; Wim Brandsma; Erik Post; Wim van Brakel; Diana Lockwood; Peter Nicholls; Paul Saunderson; Cairns Smith; Einar Wilder-Smith; Jan Hendrik Richardus
Journal:  BMC Neurol       Date:  2012-12-18       Impact factor: 2.474

7.  Early diagnosis of neuropathy in leprosy--comparing diagnostic tests in a large prospective study (the INFIR cohort study).

Authors:  Wim H van Brakel; Peter G Nicholls; Einar P Wilder-Smith; Loretta Das; Pramila Barkataki; Diana N J Lockwood
Journal:  PLoS Negl Trop Dis       Date:  2008-04-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.